News summary

Tennessee Oncology Physician Contributes to Landmark Longevity Research

Source: PR Newswire • Published: 07 Oct 2026, 18:10

Summarized by Masters of Longevity from PR Newswire.

A report introducing research into genetic and epigenetic factors behind extreme animal longevity and cancer resistance, highlighting multidisciplinary contributions and scientific implications.

Tennessee Oncology Physician Contributes to Landmark Longevity Research
Key Takeaways
  • Researchers identified 287 unique genetic variants tied to DNA repair, inflammation, insulin regulation, and cancer suppression pathways.
  • This study presents the first epigenome analysis of a giant tortoise, examining chemical gene-regulatory modifications associated with longevity.
  • A Tennessee Oncology physician contributed epigenomic analysis to a multi-institutional study led by Kallel researchers.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.